|
Code
|
Display
|
|
13361-1
|
Semen
analysis
panel
|
|
15129-0
|
Deprecated
Fibrin
D-dimer
EIA
|
|
24313-9
|
Hepatitis
1996
panel
-
Serum
|
|
24314-7
|
TORCH
1996
panel
-
Serum
|
|
24315-4
|
Cytomegalovirus
IgG
and
IgM
panel
-
Serum
|
|
24316-2
|
Epstein
Barr
virus
capsid
IgG
and
IgM
panel
-
Serum
|
|
24317-0
|
Hemogram
and
platelets
WO
differential
panel
-
Blood
|
|
24318-8
|
Manual
Differential
panel
-
Blood
|
|
24319-6
|
Cardiolipin
IgG
and
IgM
panel
-
Serum
|
|
24320-4
|
Basic
metabolic
1998
panel
-
Serum
or
Plasma
|
|
24321-2
|
Basic
metabolic
2000
panel
-
Serum
or
Plasma
|
|
24322-0
|
Comprehensive
metabolic
1998
panel
-
Serum
or
Plasma
|
|
24323-8
|
Comprehensive
metabolic
2000
panel
-
Serum
or
Plasma
|
|
24324-6
|
Hepatic
function
1996
panel
-
Serum
or
Plasma
|
|
24325-3
|
Hepatic
function
2000
panel
-
Serum
or
Plasma
|
|
24326-1
|
Electrolytes
1998
panel
-
Serum
or
Plasma
|
|
24327-9
|
Electrolytes
3
panel
-
Body
fluid
|
|
24328-7
|
Electrolytes
3
panel
-
Stool
|
|
24329-5
|
Electrolytes
3
panel
-
Urine
|
|
24331-1
|
Lipid
1996
panel
-
Serum
or
Plasma
|
|
24332-9
|
Alkaline
phosphatase
isoenz
panel
-
Serum
or
Plasma
|
|
24333-7
|
Amylase
isoenzyme
3
panel
-
Serum
or
Plasma
|
|
24334-5
|
Amylase
isoenzyme
7
panel
-
Serum
|
|
24335-2
|
Creatine
kinase
panel
-
Serum
or
Plasma
|
|
24336-0
|
Gas
panel
-
Arterial
blood
|
|
24337-8
|
Gas
panel
-
Capillary
blood
|
|
24338-6
|
Gas
panel
-
Blood
|
|
24339-4
|
Gas
panel
-
Venous
blood
|
|
24340-2
|
Gas
panel
-
Body
fluid
|
|
24341-0
|
Gas
and
Carbon
monoxide
panel
-
Arterial
blood
|
|
24342-8
|
Gas
and
Carbon
monoxide
panel
-
Capillary
blood
|
|
24343-6
|
Gas
and
Carbon
monoxide
panel
-
Blood
|
|
24344-4
|
Gas
and
Carbon
monoxide
panel
-
Venous
blood
|
|
24345-1
|
Deprecated
Gas
&
CO
panel
|
|
24346-9
|
Parathyrin.intact
and
Calcium
panel
-
Serum
or
Plasma
|
|
24347-7
|
Parathyrin.mid
molecule
and
Calcium
panel
-
Serum
or
Plasma
|
|
24348-5
|
Free
T4
and
TSH
panel
-
Serum
or
Plasma
|
|
24349-3
|
Drugs
of
abuse
5
panel
-
Urine
|
|
24350-1
|
Volatiles
panel
-
Urine
|
|
24351-9
|
Protein
electrophoresis
panel
-
Serum
or
Plasma
|
|
24352-7
|
Protein
electrophoresis
panel
-
Cerebral
spinal
fluid
|
|
24353-5
|
Glucose
tolerance
2
hours
gestational
panel
-
Urine
and
Serum
or
Plasma
|
|
24356-8
|
Urinalysis
complete
panel
-
Urine
|
|
24357-6
|
Urinalysis
macro
(dipstick)
panel
-
Urine
|
|
24358-4
|
Hemogram
without
Platelets
panel
-
Blood
|
|
24359-2
|
Hemogram
without
Platelets
and
with
Manual
Differential
panel
-
Blood
|
|
24360-0
|
Hemoglobin
and
Hematocrit
panel
-
Blood
|
|
24361-8
|
Deprecated
Hemogram,
platelets
&
Differential
panel
in
Blood
|
|
24362-6
|
Renal
function
2000
panel
-
Serum
or
Plasma
|
|
24363-4
|
Acute
hepatitis
2000
panel
-
Serum
Qualitative
|
|
24364-2
|
Obstetric
1996
panel
-
Serum
and
Blood
|
|
24365-9
|
Urinalysis
microscopic
panel
-
Urine
sediment
|
|
29576-6
|
Bacterial
susceptibility
panel
|
|
29577-4
|
Fungal
susceptibility
panel
|
|
29578-2
|
Viral
susceptibility
panel
|
|
29579-0
|
Mycobacterial
susceptibility
panel
|
|
29580-8
|
Differential
panel
-
Body
fluid
|
|
29581-6
|
Differential
panel
-
Peritoneal
fluid
|
|
29582-4
|
Differential
panel
-
Synovial
fluid
|
|
29583-2
|
Differential
panel
-
Pleural
fluid
|
|
29584-0
|
Differential
panel
-
Cerebral
spinal
fluid
|
|
29585-7
|
Immunoelectrophoresis
panel
-
Urine
|
|
29586-5
|
Immunoelectrophoresis
panel
-
Serum
|
|
29587-3
|
Toxicology
panel
-
Blood
|
|
29588-1
|
Heavy
metals
panel
-
Blood
|
|
29589-9
|
Heavy
metals
panel
-
Urine
|
|
34527-2
|
Deprecated
Hemogram,
Platelets,
Differential
&
Reticulocyte
panel
in
Blood
|
|
34528-0
|
PT
panel
-
Platelet
poor
plasma
by
Coagulation
assay
|
|
34529-8
|
PT
and
aPTT
panel
-
Platelet
poor
plasma
by
Coagulation
assay
|
|
34530-6
|
ABO
and
Rh
group
panel
-
Blood
|
|
34531-4
|
Blood
type
and
Crossmatch
panel
-
Blood
|
|
34532-2
|
Blood
type
and
Indirect
antibody
screen
panel
-
Blood
|
|
34534-8
|
EKG
12
channel
panel
|
|
34535-5
|
Microalbumin/Creatinine
panel
in
random
Urine
|
|
34536-3
|
Fluid
intake
and
output
panel
24
hour
|
|
34537-1
|
Fluid
intake
and
output
panel
8
hour
|
|
34539-7
|
Protein
electrophoresis
panel
-
Urine
|
|
34540-5
|
Phenytoin
free
and
total
panel
[Mass/volume]
-
Serum
or
Plasma
|
|
34541-3
|
ACTH
stimulation
test
using
IM
corticosteroids
in
Serum
or
Plasma
|
|
34542-1
|
ACTH
stimulation
test
using
IV
corticosteroids
in
Serum
or
Plasma
|
|
34543-9
|
Bilirubin
direct
and
total
panel
[Mass/volume]
-
Serum
or
Plasma
|
|
34544-7
|
Complement
C3
and
C4
panel
[Mass/volume]
-
Serum
or
Plasma
|
|
34545-4
|
Carbamazepine
free
and
total
panel
[Mass/volume]
-
Serum
or
Plasma
|
|
34546-2
|
Protein
and
Glucose
panel
[Mass/volume]
-
Cerebral
spinal
fluid
|
|
34547-0
|
Complement
profile
panel
[Mass/volume]
-
Serum
or
Plasma
|
|
34548-8
|
Sodium
and
Potassium
panel
[Moles/volume]
-
Serum
or
Plasma
|
|
34549-6
|
Follitropin
and
Lutropin
panel
[Units/volume]
-
Serum
or
Plasma
|
|
34550-4
|
Immunoglobulin
panel
[Mass/volume]
-
Serum
|
|
34551-2
|
Catecholamines
3
panel
[Mass/volume]
-
Plasma
|
|
34552-0
|
2D
echocardiogram
panel
|
|
34553-8
|
Orthostatic
blood
pressure
panel
|
|
34554-6
|
Electrolytes
1998
and
Venous
pH
panel
-
Serum
or
Plasma
+
Blood
venous
|
|
34555-3
|
Creatinine
24H
renal
clearance
panel
|
|
34556-1
|
Cell
count
panel
-
Body
fluid
|
|
34557-9
|
Cell
count
and
Differential
panel
-
Body
fluid
|
|
34558-7
|
Cell
count
panel
-
Peritoneal
fluid
|
|
34559-5
|
Cell
count
panel
-
Synovial
fluid
|
|
34560-3
|
Cell
count
and
Differential
panel
-
Synovial
fluid
|
|
34561-1
|
Cell
count
panel
-
Pleural
fluid
|
|
34562-9
|
Cell
count
and
Differential
panel
-
Pleural
fluid
|
|
34563-7
|
Cell
count
panel
-
Cerebral
spinal
fluid
|
|
34564-5
|
Cell
count
and
Differential
panel
-
Cerebral
spinal
fluid
|
|
34565-2
|
Vital
signs,
weight
and
height
panel
|
|
34566-0
|
Vital
signs
with
method
details
panel
|
|
34567-8
|
Cell
count
and
Differential
panel
-
Peritoneal
fluid
|
|
34665-0
|
TORCH
panel
-
Cerebral
spinal
fluid
|
|
34667-6
|
Heavy
metals
panel
-
Hair
|
|
34672-6
|
Immunoelectrophoresis
panel
-
24
hour
Urine
|
|
34940-7
|
Babesia
microti
IgG
and
IgM
panel
-
Serum
|
|
34941-5
|
Bordetella
pertussis
IgG
and
IgM
panel
-
Serum
|
|
34942-3
|
Borrelia
burgdorferi
IgG
and
IgM
panel
-
Serum
|
|
34943-1
|
Borrelia
burgdorferi
IgG
and
IgM
panel
-
Cerebral
spinal
fluid
|
|
34944-9
|
Cytomegalovirus
IgG
and
IgM
panel
-
Cerebral
spinal
fluid
|
|
34945-6
|
Herpes
virus
6
IgG
and
IgM
panel
-
Serum
|
|
34946-4
|
Herpes
virus
6
IgG
and
IgM
panel
-
Cerebral
spinal
fluid
|
|
34947-2
|
Herpes
virus
7
IgG
and
IgM
panel
-
Serum
|
|
34948-0
|
Measles
virus
IgG
and
IgM
panel
-
Serum
|
|
34949-8
|
Measles
virus
IgG
and
IgM
panel
-
Cerebral
spinal
fluid
|
|
34950-6
|
Parvovirus
B19
IgG
and
IgM
panel
-
Serum
|
|
34951-4
|
Phosphatidylserine
IgG
and
IgM
panel
-
Serum
|
|
34952-2
|
Rubella
virus
IgG
and
IgM
panel
-
Serum
|
|
34953-0
|
Rubella
virus
IgG
and
IgM
panel
-
Cerebral
spinal
fluid
|
|
34954-8
|
Treponema
pallidum
IgG
and
IgM
panel
-
Serum
|
|
34955-5
|
Western
equine
encephalitis
virus
IgG
and
IgM
panel
-
Cerebral
spinal
fluid
|
|
34994-4
|
Smear
morphology
panel
-
Blood
|
|
35083-5
|
Amino
acids
panel
[Moles/volume]
-
Serum
or
Plasma
|
|
35084-3
|
Fetal
lung
maturity
in
Amniotic
fluid
|
|
35085-0
|
Deprecated
Newborn
screening
panel
American
College
of
Medical
Genetics
(ACMG)
|
|
35086-8
|
Second
trimester
triple
maternal
screen
panel
-
Serum
or
Plasma
|
|
35087-6
|
Amino
acids
panel
-
Urine
|
|
35088-4
|
Glasgow
coma
scale
|
|
35089-2
|
History
and
physical
panel
|
|
35090-0
|
Patient
history
|
|
35091-8
|
Patient
physical
|
|
35092-6
|
Urology
testicular
ultrasound
|
|
35093-4
|
Urology
urinary
tract
ultrasound
|
|
35094-2
|
Blood
pressure
panel
|
|
35095-9
|
Body
temperature
panel
|
|
35096-7
|
OB
ultrasound
panel
|
|
35499-3
|
Pesticide
and
Insecticide
panel
[Mass/volume]
-
Serum
or
Plasma
|
|
35500-8
|
Pesticide
and
Insecticide
panel
[Mass/volume]
-
Urine
|
|
35501-6
|
Pesticide
and
Insecticide
panel
[Mass/volume]
-
Urine
and
Serum
or
Plasma
|
|
35502-4
|
Mitochondrial
myopathy
enzyme
panel
[Enzymatic
activity/mass]
-
Tissue
|
|
35507-3
|
Amino
acids
panel
[Moles/volume]
-
Cerebral
spinal
fluid
|
|
35508-1
|
Amino
acids
panel
[Moles/volume]
-
Amniotic
fluid
|
|
35509-9
|
Amino
acids
panel
[Moles/time]
-
24
hour
Urine
|
|
35558-6
|
Cholinesterase
panel
[Enzymatic
activity/volume]
-
Blood
|
|
35563-6
|
Rickettsia
rickettsii
IgG
and
IgM
panel
-
Serum
|
|
35575-0
|
Pigeon
antibody
panel
-
Serum
|
|
35576-8
|
Hydrocarbon
and
Oxygenated
Volatiles
panel
-
Serum
or
Plasma
|
|
35577-6
|
Hypersensitivity
pneumonitis
panel
-
Serum
|
|
35650-1
|
Lymphocytic
choriomeningitis
virus
IgG
and
IgM
panel
-
Cerebral
spinal
fluid
|
|
35666-7
|
Lymphocytic
choriomeningitis
virus
IgG
and
IgM
panel
-
Serum
|
|
35679-0
|
Varicella
zoster
virus
IgG
and
IgM
panel
-
Cerebral
spinal
fluid
|
|
35680-8
|
Hepatitis
E
virus
IgG
and
IgM
panel
-
Serum
|
|
35681-6
|
Tissue
transglutaminase
Ab
panel
-
Serum
|
|
35682-4
|
Trypanosoma
cruzi
IgG
and
IgM
panel
-
Serum
|
|
35683-2
|
Burkholderia
pseudomallei
IgG
and
IgM
panel
-
Serum
|
|
35684-0
|
Colorado
tick
fever
virus
IgG
and
IgM
panel
-
Serum
|
|
35739-2
|
Brucella
sp
IgG
and
IgM
panel
-
Serum
|
|
35740-0
|
Rickettsia
sp
IgG
and
IgM
panel
-
Serum
|
|
35743-4
|
Eastern
equine
encephalitis
virus
IgG
and
IgM
panel
-
Unspecified
specimen
|
|
35752-5
|
Escherichia
coli
O157:H7
IgG
and
IgM
panel
-
Serum
|
|
35866-3
|
Organic
acids
panel
-
Serum
or
Plasma
|
|
38212-7
|
Pain
assessment
panel
|
|
38213-5
|
FLACC
pain
assessment
panel
|
|
38228-3
|
Braden
scale
skin
assessment
panel
|
|
38269-7
|
Study
report
Skeletal
system
DXA
|
|
38351-3
|
Herpes
virus
6
DNA
panel
-
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
39135-9
|
Wound
assessment
panel
|
|
39136-7
|
Deprecated
Skin
assessment
panel
|
|
39137-5
|
Oral
assessment
panel
|
|
41359-1
|
Active
range
of
motion
panel
Quantitative
|
|
41360-9
|
Passive
range
of
motion
panel
Quantitative
|
|
41478-9
|
Bartonella
henselae
IgG
and
IgM
panel
-
Serum
|
|
41482-1
|
Chlamydia
sp
IgG
and
IgM
panel
[Titer]
-
Serum
|
|
41484-7
|
Coxsackievirus
A
Ab
panel
[Titer]
-
Serum
by
Complement
fixation
|
|
41485-4
|
Coxsackievirus
B
Ab
panel
[Titer]
-
Serum
by
Complement
fixation
|
|
41486-2
|
Coxsackievirus
B
Ab
panel
[Titer]
-
Serum
by
Neutralization
test
|
|
41493-8
|
Febrile
agglutinin
Ab
panel
[Titer]
-
Serum
|
|
41505-9
|
Parainfluenza
virus
Ag
panel
-
Unspecified
specimen
by
Immunofluorescence
|
|
41506-7
|
Polio
virus
Ab
panel
[Titer]
-
Serum
by
Neutralization
test
|
|
41839-2
|
Burkholderia
pseudomallei
IgG
and
IgM
panel
-
Serum
by
Immunofluorescence
|
|
41840-0
|
Coxiella
burnetii
phase
1
and
2
IgG
panel
[Titer]
-
Serum
|
|
41841-8
|
Coxiella
burnetii
phase
1
and
2
IgM
panel
[Titer]
-
Serum
|
|
41842-6
|
Herpes
virus
7
IgG
and
IgM
panel
[Titer]
-
Serum
by
Immunofluorescence
|
|
41843-4
|
Lymphocytic
choriomeningitis
virus
IgG
and
IgM
panel
[Titer]
-
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
41875-6
|
Bordetella
pertussis
and
Bordetella
parapertussis
DNA
panel
-
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
41876-4
|
Rickettsia
typhi
and
Rickettsia
spotted
fever
group
IgG
and
IgM
panel
-
Serum
|
|
41877-2
|
Bordetella
pertussis
IgA
and
IgG
and
IgM
panel
[Units/volume]
-
Serum
by
Immunoassay
|
|
41878-0
|
Dengue
virus
IgG
and
IgM
panel
[Units/volume]
-
Serum
by
Immunoassay
|
|
42191-7
|
Hepatitis
A
and
B
and
C
7a
panel
-
Serum
|
|
42218-8
|
Sulfatide
IgG
and
IgM
panel
-
Serum
|
|
42342-6
|
Rickettsia
(Proteus)
Ab
panel
-
Serum
|
|
42359-0
|
Streptococcus
pneumoniae
14b
IgG
panel
[Mass/volume]
-
Serum
|
|
42360-8
|
Streptococcus
pneumoniae
14a
IgG
panel
[Mass/volume]
-
Serum
|
|
42361-6
|
Streptococcus
pneumoniae
12
IgG
panel
[Mass/volume]
-
Serum
|
|
42362-4
|
Streptococcus
pneumoniae
7b
IgG
panel
[Mass/volume]
-
Serum
|
|
42363-2
|
Streptococcus
pneumoniae
7a
IgG
panel
[Mass/volume]
-
Serum
|
|
42364-0
|
Streptococcus
pneumoniae
6
IgG
panel
[Mass/volume]
-
Serum
|
|
42365-7
|
Streptococcus
pneumoniae
4
IgG
panel
[Mass/volume]
-
Serum
|
|
42366-5
|
Streptococcus
pneumoniae
23
IgG
panel
[Mass/volume]
-
Serum
|
|
42760-9
|
Inflammatory
bowel
disease
Ab
panel
-
Serum
|
|
42770-8
|
Human
papilloma
virus
high
and
Low
risk
DNA
panel
-
Cervix
|
|
42929-0
|
Lactate
dehydrogenase
panel
-
Serum
or
Plasma
|
|
43098-3
|
Yersinia
sp
Ab
panel
-
Serum
|
|
43099-1
|
Vanillylmandelate
panel
-
24
hour
Urine
|
|
43100-7
|
Sjogrens
syndrome-A
and
B
extractable
nuclear
Ab
panel
-
Serum
|
|
43101-5
|
Phosphatidylserine
IgA
and
IgG
and
IgM
panel
-
Serum
|
|
43104-9
|
Paraneoplastic
Ab
panel
-
Serum
|
|
43105-6
|
Acetaldehyde
and
Paraldehyde
panel
[Mass/volume]
-
Serum
or
Plasma
|
|
43106-4
|
Amitriptyline
and
Nortriptyline
panel
[Mass/volume]
-
Serum
or
Plasma
|
|
43107-2
|
Mycoplasma
sp
and
Ureaplasma
sp
panel
-
Unspecified
specimen
by
Organism
specific
culture
|
|
43108-0
|
Metanephrine
and
Normetanephrine
panel
[Mass/volume]
-
Serum
or
Plasma
|
|
43109-8
|
Leishmania
sp
IgG
and
IgM
panel
-
Serum
|
|
43110-6
|
Immunoglobulin
light
chains
panel
-
24
hour
Urine
|
|
43112-2
|
Herpes
simplex
virus
Ab
panel
-
Serum
|
|
43113-0
|
Hemoglobin
electrophoresis
panel
in
Blood
|
|
43116-3
|
Porphyrin
fractions
panel
-
24
hour
Urine
|
|
43117-1
|
Fluoxetine
and
Norfluoxetine
panel
[Mass/volume]
-
Serum
or
Plasma
|
|
43118-9
|
Fat
panel
-
Stool
|
|
43119-7
|
Extractable
nuclear
Ab
panel
-
Serum
|
|
43120-5
|
Echovirus
Ab
panel
-
Serum
|
|
43122-1
|
Doxepin
and
Nordoxepin
panel
[Mass/volume]
-
Serum
or
Plasma
|
|
43123-9
|
Imipramine
and
Desipramine
panel
[Mass/volume]
-
Serum
or
Plasma
|
|
43124-7
|
Cystine
panel
-
Urine
|
|
43125-4
|
Nicotine
and
Metabolites
panel
[Mass/volume]
-
Urine
|
|
43126-2
|
Cortisol.free
panel
-
24
hour
Urine
|
|
43127-0
|
Clomipramine
and
Norclomipramine
panel
[Mass/volume]
-
Serum
or
Plasma
|
|
43128-8
|
Chloride
panel
-
24
hour
Urine
|
|
43129-6
|
Brucella
abortus
IgG
and
IgM
panel
-
Serum
|
|
43130-4
|
Bile
acid
fractions
panel
[Moles/volume]
-
Serum
|
|
43131-2
|
Bacterial
Ag
panel
-
Cerebral
spinal
fluid
|
|
43133-8
|
Allopurinol
and
Oxipurinol
panel
[Mass/volume]
-
Serum
or
Plasma
|
|
43134-6
|
Calcidiol
and
Calciferol
and
Calcitriol
panel
[Mass/volume]
-
Serum
or
Plasma
|
|
43135-3
|
17-Ketosteroids
and
17-Ketogenic
steroids
panel
-
24
hour
Urine
|
|
43141-1
|
Synthetic
glucocorticoid
panel
[Mass/volume]
-
Serum
or
Plasma
|
|
43142-9
|
Height
measurement
device
panel
|
|
43143-7
|
Weighing
device
panel
|
|
43144-5
|
Pedometer
device
panel
|
|
43145-2
|
Peak
flow
meter
device
panel
|
|
43146-0
|
Oxygen
saturation
device
panel
|
|
43147-8
|
Metabolism
measurement
device
panel
|
|
43148-6
|
Insulin
delivery
device
panel
|
|
43149-4
|
Heart
rate
device
panel
|
|
43150-2
|
Hemoglobin
A1c
measurement
device
panel
|
|
43151-0
|
Glucose
meter
device
panel
|
|
43152-8
|
Blood
pressure
device
panel
|
|
43153-6
|
Blood
coagulation
device
panel
|
|
43309-4
|
Desmoglein
1
and
Desmoglein
3
Ab
panel
[Units/volume]
-
Serum
|
|
43433-2
|
Acylcarnitine
panel
-
Serum
or
Plasma
|
|
43434-0
|
Bacterial
Ag
panel
-
Serum
|
|
43435-7
|
Bartonella
henselae
and
Bartonella
quintana
IgM
panel
-
Cerebral
spinal
fluid
|
|
43436-5
|
Bartonella
henselae
and
Bartonella
quintana
IgG
panel
-
Cerebral
spinal
fluid
|
|
43437-3
|
Bartonella
henselae
and
Bartonella
quintana
IgG
and
IgM
panel
-
Cerebral
spinal
fluid
|
|
43438-1
|
Bartonella
henselae
and
Bartonella
quintana
IgG
and
IgM
panel
-
Serum
|
|
43439-9
|
Bartonella
henselae
and
Bartonella
quintana
IgG
panel
[Titer]
-
Serum
|
|
43440-7
|
Bartonella
henselae
and
Bartonella
quintana
IgM
panel
[Titer]
-
Serum
|
|
43443-1
|
Bacterial
Ag
panel
-
Urine
|
|
43674-1
|
Fatty
Acid
Panel
Comprehensive
C8-C26
-
Serum
or
Plasma
|
|
43675-8
|
Fatty
Acid
Panel
Mitochondrial
C8-C18
-
Serum
or
Plasma
|
|
43676-6
|
Fatty
Acid
Panel
Essential
C12-C22
-
Serum
or
Plasma
|
|
43677-4
|
Fatty
Acid
Panel
Peroxisomal
C22-C26
-
Serum
or
Plasma
|
|
44249-1
|
PHQ-9
quick
depression
assessment
panel
[Reported.PHQ]
|
|
44616-1
|
Pulse
oximetry
panel
|
|
4463-6
|
Spermatozoa
motility
and
count
panel
|
|
44789-6
|
Amylase
and
Creatinine
clearance
panel
-
Urine
and
Serum
or
Plasma
|
|
44791-2
|
Menorrhagia
coagulation
panel
-
Platelet
poor
plasma
|
|
44792-0
|
Immunoglobulin
light
chains
panel
-
Urine
|
|
44793-8
|
Immunoglobulin
light
chains
panel
[Mass/volume]
-
Serum
|
|
44906-6
|
Homovanillate
panel
-
24
hour
Urine
|
|
44907-4
|
5-Hydroxyindoleacetate
panel
-
24
hour
Urine
|
|
45023-9
|
HLA
typing
for
celiac
disease
panel
-
Blood
|
|
45024-7
|
HLA
typing
for
narcolepsy
panel
-
Blood
|
|
45027-0
|
HLA-A2
panel
-
Blood
|
|
45033-8
|
Cardiovascular
assessment
panel
|
|
45057-7
|
Cardiolipin
IgA
and
IgG
and
IgM
panel
-
Serum
|
|
45058-5
|
Cyclosporine
Monoclonal
and
Polyclonal
panel
[Mass/volume]
-
Blood
|
|
45059-3
|
Ehrlichia
chaffeensis
IgG
and
IgM
panel
[Titer]
-
unspecified
time
Serum
by
Immunofluorescence
|
|
45060-1
|
Protein
and
Glucose
panel
-
Urine
by
Test
strip
|
|
45061-9
|
Spermatozoa
IgA
and
IgG
and
IgM
panel
-
Serum
|
|
45063-5
|
Varicella
zoster
virus
IgG
and
IgM
panel
-
Serum
|
|
45064-3
|
Deprecated
Basic
metabolic
panel
&
Glomerular
filtration
rate.predicted
|
|
45065-0
|
Deprecated
Comprehensive
metabolic
panel
&
Glomerular
filtration
rate.predicted
|
|
45066-8
|
Creatinine
and
Glomerular
filtration
rate.predicted
panel
|
|
45174-0
|
Herpes
gestationis
Ab
panel
-
Serum
|
|
45268-0
|
Immunodeficiency
panel
-
Blood
by
Flow
cytometry
(FC)
|
|
45269-8
|
Chronic
leukemia
panel
-
Unspecified
specimen
by
Flow
cytometry
(FC)
|
|
45270-6
|
Acute
leukemia
panel
-
Unspecified
specimen
by
Flow
cytometry
(FC)
|
|
45350-6
|
Tick
identification
panel
|
|
45962-8
|
Minimum
data
set
for
nursing
home
resident
assessment
and
care
screen
|
|
45963-6
|
MDS
basic
assessment
tracking
form
-
version
2.0
|
|
45964-4
|
Identification
information
section
|
|
45965-1
|
Name
Set
|
|
45966-9
|
Social
security
and
medicare
numbers
Set
|
|
45967-7
|
Facility
provider
numbers
Set
|
|
45968-5
|
Reasons
for
assessment
(basic)
Set
|
|
45969-3
|
MDS
background
information
at
admission
form
-
version
2.0
|
|
45970-1
|
Demographic
information
section
|
|
45971-9
|
Residential
history
5
years
prior
to
entry
Set
|
|
45972-7
|
Language
Set
|
|
45973-5
|
Conditions
related
to
mental
retardation
and
developmental
disabilities
status
Set
|
|
45974-3
|
Mental
retardation
and
developmental
disabilities
with
organic
condition
Set
|
|
45975-0
|
Customary
routine
section
|
|
45976-8
|
Customary
routine
in
year
prior
to
date
of
entry
Set
|
|
45977-6
|
Cycle
of
daily
events
Set
|
|
45978-4
|
Eating
patterns
Set
|
|
45979-2
|
ADL
patterns
Set
|
|
45980-0
|
Involvement
patterns
Set
|
|
45981-8
|
MDS
full
assessment
form
-
version
2.0
|
|
45982-6
|
Identification
and
background
information
section
|
|
45983-4
|
Assessment
reference
date
Set
|
|
45984-2
|
Current
payment
sources
for
nursing
home
stay
Set
|
|
45985-9
|
Responsibility/legal
guardian
Set
|
|
45986-7
|
Advance
directives
Set
|
|
45987-5
|
Cognitive
patterns
section
|
|
45988-3
|
Memory
Set
|
|
45989-1
|
Memory
recall/ability
Set
|
|
45990-9
|
Indicators
of
delirium
-
periodic
disorded
thinking
or
awareness
Set
|
|
45991-7
|
Communication
and
hearing
patterns
section
|
|
45992-5
|
Communication
devices
and
techniques
Set
|
|
45993-3
|
Modes
of
expression
Set
|
|
45994-1
|
Vision
patterns
section
|
|
45995-8
|
Visual
limitations
and
dificulties
Set
|
|
45996-6
|
Mood
and
behavior
patterns
section
|
|
45997-4
|
Indicators
of
depression,
anxiety,
sad
mood
Set
|
|
45998-2
|
Verbal
expressions
of
distress
Set
|
|
45999-0
|
Sleep-cycle
issues
Set
|
|
46000-6
|
Sad,
apethetic,
anxious
appearance
Set
|
|
46001-4
|
Behavioral
symptoms
Set
|
|
46002-2
|
Psychosocial
well-being
section
|
|
46003-0
|
Sense
of
initiative/involvement
Set
|
|
46004-8
|
Unsettled
releationships
Set
|
|
46005-5
|
Past
roles
Set
|
|
46006-3
|
Physical
functioning
and
stuctural
problems
section
Set
|
|
46007-1
|
ADL
self
performance
or
support
Set
|
|
46008-9
|
Bathing
|
|
46009-7
|
Test
for
balance
Set
|
|
46010-5
|
Functional
limitation
in
range
of
motion
Set
|
|
46011-3
|
Modes
of
locomotion
Set
|
|
46012-1
|
Modes
of
transfer
Set
|
|
46013-9
|
ADL
functional
rehabilitation
potential
Set
|
|
46014-7
|
Continence
in
last
14
days
section
Set
|
|
46015-4
|
Continence
self-control
categories
Set
|
|
46016-2
|
Bowel
elimination
pattern
Set
|
|
46017-0
|
Continence
appliances
and
programs
Set
|
|
46018-8
|
Disease
or
condition
diagnoses
section
|
|
46019-6
|
Diseases
or
conditions
Set
|
|
46020-4
|
Endocrine,
metabolic
or
nutritional
diseases
or
conditions
Set
|
|
46021-2
|
Heart
or
circulation
diseases
or
conditions
Set
|
|
46022-0
|
Musculoskeletal
diseases
or
conditions
Set
|
|
46023-8
|
Neurological
diseases
or
conditions
Set
|
|
46024-6
|
Psychiatric
or
mood
diseases
or
conditions
Set
|
|
46025-3
|
Pulmonary
diseases
or
conditions
Set
|
|
46026-1
|
Sensory
diseases
or
conditions
Set
|
|
46027-9
|
Other
diseases
or
conditions
Set
|
|
46028-7
|
Infections
Set
|
|
46029-5
|
Other
current
or
more
detailed
diagnoses
and
ICD9
codes
Set
|
|
46030-3
|
Health
conditions
section
|
|
46031-1
|
Indicators
of
fluid
status
Set
|
|
46032-9
|
Other
indicators
Set
|
|
46033-7
|
Pain
symptoms
Set
|
|
46034-5
|
Pain
site
Set
|
|
46035-2
|
Accidents
Set
|
|
46036-0
|
Stability
of
conditions
Set
|
|
46037-8
|
Oral
and
nutritional
status
section
|
|
46038-6
|
Oral
problems
Set
|
|
46039-4
|
Height
and
weight
Set
|
|
46040-2
|
Weight
change
Set
|
|
46041-0
|
Nutritional
problems
Set
|
|
46042-8
|
Nutritional
approaches
Set
|
|
46043-6
|
Parenteral
or
enteral
intake
Set
|
|
46044-4
|
Oral
or
dental
status
section
|
|
46045-1
|
Oral
status
and
disease
prevention
Set
|
|
46046-9
|
Skin
condition
section
|
|
46047-7
|
Ulcers
Set
|
|
46048-5
|
Type
of
ulcer
Set
|
|
46049-3
|
Other
skin
problems
or
lesions
present
Set
|
|
46050-1
|
Skin
treatments
Set
|
|
46051-9
|
Foot
problems
and
care
Set
|
|
46052-7
|
Activity
pursuit
patterns
section
|
|
46053-5
|
Time
awake
Set
|
|
46054-3
|
Preferred
activity
settings
Set
|
|
46055-0
|
General
activity
preferences
Set
|
|
46056-8
|
Prefers
change
in
daily
routine
Set
|
|
46057-6
|
Medications
section
|
|
46058-4
|
Days
received
the
following
places:
medication
Set
|
DiagnosticOrder.item.code
(
Incomplete
46059-2
|
Special
treatments
and
procedures
section
|
)
The
OID
46060-0
|
Special
treatments,
procedures
and
programs
Set
|
|
46061-8
|
Special
care
Set
|
|
46062-6
|
Treatments
Set
|
|
46063-4
|
Programs
Set
|
|
46064-2
|
Therapies
Set
|
|
46065-9
|
Intervention
programs
for
the
value
set
is
2.16.840.1.113883.4.642.2.59
(OIDs
are
not
used
mood,
behavior
and
cognitive
loss
Set
|
|
46066-7
|
Nursing
rehabilitation
and
restorative
care
Set
|
|
46067-5
|
Devices
and
restraints
Set
|
|
46068-3
|
Discharge
potential
and
overall
status
section
|
|
46069-1
|
Discharge
potential
Set
|
|
46070-9
|
Assessment
information
section
|
|
46071-7
|
Participation
in
FHIR,
but
may
be
used
assessment
Set
|
|
46072-5
|
Therapy
supplement
for
Medicare
PPS
section
|
|
46073-3
|
Special
treatments
and
procedures
Set
|
|
46074-1
|
Recreational
therapy
Set
|
|
46075-8
|
Walking
when
most
self
sufficient
Set
|
|
46076-6
|
Minimum
Data
Set
(MDS)
supplemental
items
section
-
version
2.0
|
|
46077-4
|
Influenza
vaccine
Set
|
|
46078-2
|
Pneumococcal
vaccine
Set
|
|
46079-0
|
Resident
assessment
protocol
summary
section
|
|
46101-2
|
Ordered
therapies
Set
|
|
46102-0
|
MDS
quarterly
assessment
form
-
version
2.0
|
|
46103-8
|
MDS
quarterly
assessment
form
-
version
2.0
-
optional
version
for
RUG-III
|
|
46104-6
|
MDS
quarterly
assessment
form
-
version
2.0
-
optional
version
for
RUG-III
1997
update
|
|
46105-3
|
Problem
conditions
Set
|
|
46107-9
|
Loss
of
interest
Set
|
|
46437-0
|
Rheumatoid
Factor
and
Cyclic
Citrullinated
Peptide
IgG
panel
[Units/volume]
-
Serum
|
|
46611-0
|
Mental
residual
functional
capacity
(RFC)
assessment
form
|
|
46612-8
|
Summary
conclusions
Set
|
|
46637-5
|
Residual
physical
functional
capacity
(RFC)
assessment
form
[RFC]
|
|
46959-3
|
Synthetic
glucocorticoid
panel
[Mass/volume]
-
Urine
|
|
46993-2
|
HLA
Ab
panel
-
Serum
|
|
46999-9
|
Bacterial
vaginosis
and
vaginitis
rRNA
panel
-
Vaginal
fluid
by
DNA
probe
|
|
47245-6
|
HIV
treatment
form
Document
|
|
47246-4
|
HIV
Antiretroviral
therapy
Demographic
information
section
|
|
47248-0
|
HIV
Antiretroviral
therapy
Antiretroviral
therapy
status
section
|
|
47249-8
|
HIV
Antiretroviral
therapy
HIV
care
and
family
status
section
|
|
47286-0
|
Differential
panel
-
Bone
marrow
|
|
47287-8
|
Deprecated
Hemogram
without
Platelets
panel
in
v3,
Cord
blood
|
|
47288-6
|
CBC
WO
Differential
panel
-
Cord
blood
|
|
47289-4
|
IgG
and
IgG
subclass
panel
[Mass/volume]
-
Serum
|
|
47290-2
|
IgG
subclass
panel
[Mass/volume]
-
Serum
|
|
47531-9
|
Wet
mount
panel
-
Vaginal
fluid
|
|
48073-1
|
Thyroxine
binding
globulin
panel
[Mass/volume]
-
Serum
or
OID
Plasma
by
Electrophoresis
|
|
48593-8
|
von
Willebrand
panel
-
Platelet
poor
plasma
|
|
48596-1
|
Activated
protein
C
resistance
panel
-
Platelet
poor
plasma
|
|
48615-9
|
Insulin.free
and
Insulin.total
panel
[Units/volume]
-
Serum
or
Plasma
|
|
48644-9
|
Vanillylmandelate
and
Homovanillate
panel
-
24
hour
Urine
|
|
48760-3
|
3-Hydroxy
fatty
acid
panel
-
Serum
or
Plasma
|
|
48770-2
|
Fetal
Biophysical
profile
panel
US
|
|
48796-7
|
Hepatitis
C
virus
FibroSURE
panel
-
Serum
or
Plasma
|
|
48797-5
|
Organic
acids
panel
-
Urine
|
|
48798-3
|
First
trimester
maternal
screen
panel
-
Serum
or
Plasma
|
|
48799-1
|
Second
trimester
penta
maternal
screen
panel
-
Serum
or
Plasma
|
|
48800-7
|
Second
trimester
quad
maternal
screen
panel
-
Serum
or
Plasma
|
|
48802-3
|
Alpha-1-Fetoprotein
panel
-
Serum
or
Plasma
|
|
48805-6
|
Platelet
aggregation
panel
-
Platelet
rich
plasma
|
|
48808-0
|
Leukogram
panel
-
Blood
|
|
48809-8
|
Erythrogram
panel
-
Blood
|
|
48811-4
|
Protein
fractions
3
panel
-
Serum
or
Plasma
|
|
48812-2
|
Spermatozoa
morphology
panel
|
|
48824-7
|
Respiratory
allergen
panel,
US
-
North
Atlantic
states
a
-
Serum
|
|
48825-4
|
Respiratory
allergen
panel,
US
-
Mid
Atlantic
states
-
Serum
|
|
48826-2
|
Respiratory
allergen
panel,
US
-
South
Atlantic
states
a
-
Serum
|
|
48827-0
|
Respiratory
allergen
panel,
US
-
Subtropical
Florida
-
Serum
|
|
48828-8
|
Respiratory
allergen
panel,
US
-
Greater
Ohio
valley
a
-
Serum
|
|
48829-6
|
Respiratory
allergen
panel,
US
-
South
central
states
-
Serum
|
|
48830-4
|
Respiratory
allergen
panel,
US
-
Northern
midwest
states
a
-
Serum
|
|
48831-2
|
Respiratory
allergen
panel,
US
-
Central
midwest
a
-
Serum
|
|
48832-0
|
Respiratory
allergen
panel,
US
-
Great
plains
states
a
-
Serum
|
|
48833-8
|
Respiratory
allergen
panel,
US
-
Southwestern
grassland
states
-
Serum
|
|
48834-6
|
Respiratory
allergen
panel,
US
-
Rocky
mountain
states
a
-
Serum
|
|
48835-3
|
Respiratory
allergen
panel,
US
-
Arid
southwest
-
Serum
|
|
48836-1
|
Respiratory
allergen
panel,
US
-
Southern
coastal
California
-
Serum
|
|
48837-9
|
Respiratory
allergen
panel,
US
-
California
central
valley
-
Serum
|
|
48838-7
|
Respiratory
allergen
panel,
US
-
Intermountain
west
a
-
Serum
|
|
48839-5
|
Respiratory
allergen
panel,
US
-
Inland
northwest
a
-
Serum
|
|
48840-3
|
Respiratory
allergen
panel,
US
-
Cascade
Pacific
northwest
a
-
Serum
|
|
48841-1
|
Respiratory
allergen
panel,
US
-
Alaska
a
-
Serum
|
|
48916-1
|
Respiratory
allergen
panel,
US
-
North
Atlantic
states
b
-
Serum
|
|
48917-9
|
Respiratory
allergen
panel,
US
-
South
Atlantic
states
b
-
Serum
|
|
48918-7
|
Respiratory
allergen
panel,
US
-
NC,
PA,
SC,
VA,
WV
-
Serum
|
|
48919-5
|
Respiratory
allergen
panel,
US
-
Central
Florida
-
Serum
|
|
48920-3
|
Respiratory
allergen
panel,
US
-
Southern
Florida
-
Serum
|
|
48921-1
|
Respiratory
allergen
panel,
US
-
Southeast
coast
-
Serum
|
|
48922-9
|
Respiratory
allergen
panel,
US
-
West
south
central
states
-
Serum
|
|
48923-7
|
Respiratory
allergen
panel,
US
-
Greater
Ohio
valley
b
-
Serum
|
|
48924-5
|
Respiratory
allergen
panel,
US
-
Northern
midwest
states
b
-
Serum
|
|
48925-2
|
Respiratory
allergen
panel,
US
-
Central
midwest
b
-
Serum
|
|
48926-0
|
Respiratory
allergen
panel,
US
-
Great
plains
states
b
-
Serum
|
|
48927-8
|
Respiratory
allergen
panel,
US
-
Rocky
mountain
states
b
-
Serum
|
|
48928-6
|
Respiratory
allergen
panel,
US
-
Inland
northwest
b
-
Serum
|
|
48929-4
|
Respiratory
allergen
panel,
US
-
Cascade
Pacific
northwest
b
-
Serum
|
|
48930-2
|
Respiratory
allergen
panel,
US
-
Intermountain
west
b
-
Serum
|
|
48931-0
|
Respiratory
allergen
panel,
US
-
AZ,
Southeastern
CA,
Western
NM
-
Serum
|
|
48932-8
|
Respiratory
allergen
panel,
US
-
Alaska
b
-
Serum
|
|
48933-6
|
Respiratory
allergen
panel,
US
-
Hawaii
-
Serum
|
|
49017-7
|
Respiratory
allergen
panel,
US
-
North
Atlantic
states
c
-
Serum
|
|
49018-5
|
Respiratory
allergen
panel,
US
-
Intermountain
west
c
-
Serum
|
|
49019-3
|
Respiratory
allergen
panel,
US
-
Puerto
Rico
-
Serum
|
|
49020-1
|
Respiratory
allergen
panel,
US
-
Coastal
California
-
Serum
|
|
49021-9
|
Respiratory
allergen
panel,
US
-
Greater
Ohio
valley
c
-
Serum
|
|
49022-7
|
Respiratory
allergen
panel,
US
-
Northern
midwest
states
c
-
Serum
|
|
49037-5
|
Respiratory
syncytial
virus
IgG
and
IgM
panel
[Units/volume]
-
Serum
|
|
49044-1
|
Diazepam
and
Nordiazepam
panel
[Mass/volume]
-
Serum
or
Plasma
|
|
49045-8
|
PT
and
aPTT
and
Fibrinogen
panel
-
Platelet
poor
plasma
by
Coagulation
assay
|
|
49085-4
|
First
and
Second
trimester
integrated
maternal
screen
panel
|
|
49086-2
|
First
trimester
maternal
screen
with
nuchal
translucency
panel
|
|
49087-0
|
Maternal
screen
clinical
predictors
panel
|
|
49093-8
|
Arbovirus
IgG
and
IgM
panel
-
Serum
by
Immunofluorescence
|
|
49094-6
|
Arbovirus
IgG
and
IgM
panel
-
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
49120-9
|
Immunodeficiency
follow-up
panel
-
Unspecified
specimen
by
Flow
cytometry
(FC)
|
|
49143-1
|
North
American
Association
of
Central
Cancer
Registries,
Inc
(NAACCR,
Inc)
Pathology
Laboratory
Electronic
Reporting
panel
|
|
49222-3
|
Food
allergen
panel
-
Serum
|
|
49589-5
|
Bacterial
susceptibility
panel
by
Gradient
strip
(E-test)
|
|
49660-4
|
HIV
genotype
panel
|
|
49665-3
|
HIV
phenotype
panel
|
|
49883-2
|
Hepatitis
B
virus
resistance
panel
by
Genotype
method
|
|
49885-7
|
Lymphocyte
proliferation.beryllium
stimulation
panel
-
Blood
|
|
50009-0
|
Fetal
lung
maturity
panel
-
Amniotic
fluid
|
|
50023-1
|
Hepatitis
C
virus
RNA
panel
(viral
load)
in
Serum
or
Plasma
by
Probe
and
target
amplification
method
|
|
50025-6
|
Volatiles
panel
-
Serum
or
Plasma
|
|
50179-1
|
Calcitonin
Calcium
and
Pentagastrin
challenge
panel
-
Serum
or
Plasma
|
|
50189-0
|
Neonatal
bilirubin
panel
[Mass/volume]
-
Serum
or
Plasma
|
|
50190-8
|
Iron
and
Iron
binding
capacity
panel
-
Serum
or
Plasma
|
|
50191-6
|
Occult
blood
panel
-
Gastric
fluid
|
|
50196-5
|
Occult
blood
panel
-
Stool
|
|
50197-3
|
aPTT
panel
-
Platelet
poor
plasma
|
|
50219-5
|
Respiratory
virus
DNA
and
RNA
panel
-
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
50261-7
|
Deprecated
Renal
function
panel
&
Glomerular
filtration
rate.predicted
|
|
50262-5
|
Reticulocytes
panel
-
Blood
|
|
50334-2
|
Acylglycines
panel
[Mass
Ratio]
-
Urine
|
|
50337-5
|
Carbamazepine
free
and
total
and
10,11-Epoxide
panel
[Mass/volume]
-
Serum
or
Plasma
|
|
50399-5
|
Deprecated
Clinical
genetic
report
summary
panel
in
Blood
or
Tissue
by
Molecular
genetics
method
|
|
50545-3
|
Bacterial
susceptibility
panel
by
Minimum
inhibitory
concentration
(MIC)
|
|
50546-1
|
Bacterial
susceptibility
panel
by
Disk
diffusion
(KB)
|
|
50554-5
|
Urinalysis
microscopic
panel
[#/volume]
-
Urine
by
Automated
count
|
|
50556-0
|
Urinalysis
dipstick
panel
-
Urine
by
Automated
test
strip
|
|
50564-4
|
Urinalysis
panel
-
Urine
by
Auto
|
|
50579-2
|
Gastric
analysis
panel
-
Gastric
fluid
|
|
50580-0
|
Maternal
screen
for
fetal
abnormalities
such
as
Open
Neural
Tube
Defects,
Trisomy
21
or
Trisomy
18
panel
-
Serum
or
Plasma
|
|
50581-8
|
Adenosine
monophosphate.cyclic
stimulation
panel
-
Urine
|
|
50582-6
|
Glucose
tolerance
gestational
panel
-
Urine
and
Serum
or
Plasma
|
|
50583-4
|
Glucose
screen
gestational
panel
-
Urine
and
Serum
or
Plasma
|
|
50584-2
|
Lactose
challenge
(hydrogen
breath
test)
panel
-
Exhaled
gas
|
|
50585-9
|
Triple
bolus
stimulation
panel
-
Serum
or
Plasma
|
|
50586-7
|
Glucose
tolerance
3
hours
panel
-
Serum
or
Plasma
|
|
50587-5
|
Glucose
tolerance
4
hours
panel
-
Serum
or
Plasma
|
|
50588-3
|
Glucose
tolerance
5
hours
panel
-
Serum
or
Plasma
|
|
50589-1
|
Glucose
tolerance
6
hours
panel
-
Serum
or
Plasma
|
|
50604-8
|
HPA
panel
[Type]
in
Blood
|
|
50607-1
|
Neisseria
meningitidis
Ag
panel
-
Unspecified
specimen
by
Latex
agglutination
|
|
50608-9
|
Glucose
tolerance
3
hours
gestational
panel
-
Serum
or
Plasma
|
|
50624-6
|
HIV
1
RNA
panel
(viral
load)
in
Cerebral
spinal
fluid
by
Probe
and
target
amplification
method
|
|
50673-3
|
Insulin
XXX
challenge
panel
-
Serum
|
|
50676-6
|
Calcium-phosphorus
product
panel
[Mass/volume]
-
Serum
or
Plasma
|
|
50677-4
|
Semen
analysis
post
vasectomy
panel
|
|
50710-3
|
Influenza
virus
susceptibility
panel
|
|
50736-8
|
Serotonin
release.heparin.unfractionated
panel
-
Serum
|
|
50737-6
|
Serotonin
release.heparin.porcine
panel
-
Serum
|
|
50738-4
|
Serotonin
release.heparin.low
molecular
weight
panel
-
Serum
|
|
50739-2
|
Serotonin
release.heparin.porcine
and
low
molecular
weight
panel
-
Serum
|
|
50943-0
|
Reasons
for
assessment
(full)
Set
|
|
51410-9
|
Environmental
stressors
panel
-
Water
|
|
51411-7
|
Environmental
stressors
panel
-
Air
|
|
51662-5
|
Core
respiratory
allergens
panel
-
Serum
|
|
51782-1
|
Drugs
of
abuse
7
and
Alcohol
and
Tricyclics
panel
-
Urine
by
Screen
method
|
|
51956-1
|
DNA
region
analysis
test
coverage
panel
-
Blood
or
Tissue
by
Molecular
genetics
method
|
|
51960-3
|
DNA
marker
results
panel
-
Blood
or
Tissue
by
Molecular
genetics
method
|
|
51962-9
|
Pharmacogenetic
DNA
analysis
panel
-
Blood
or
Tissue
by
Molecular
genetics
method
|
|
51966-0
|
Genetic
disease
DNA
analysis
panel
-
Blood
or
Tissue
by
Molecular
genetics
method
|
|
51972-8
|
Gas
panel
-
Venous
cord
blood
|
|
51973-6
|
Gas
panel
-
Mixed
venous
blood
|
|
51974-4
|
Gas
panel
-
Arterial
cord
blood
|
|
51990-0
|
Basic
metabolic
panel
-
Blood
|
|
51991-8
|
Reference
lab
test
panel
|
|
51992-6
|
Heavy
metals
panel
-
Serum
or
Plasma
|
|
51993-4
|
Metanephrine
and
Normetanephrine
panel
[Mass/volume]
-
Urine
|
|
52135-1
|
t(9;22)(q34.1;q11)(ABL1,BCR)
transcript
detection
panel
-
Blood
or
Tissue
by
Molecular
genetics
method
|
|
52762-2
|
Intrinsic
coagulation
system
thromboelastography
panel
-
Blood
|
|
52763-0
|
Extrinsic
coagulation
system
thromboelastography
panel
-
Blood
|
|
52764-8
|
Extrinsic
coagulation
system
with
fibrinolysis
inhibition
thromboelastography
panel
-
Blood
|
|
52765-5
|
Thromboelastography
without
activation
panel
-
Blood
|
|
52777-0
|
Intrinsic
coagulation
system
with
heparin
inhibition
thromboelastography
panel
-
Blood
|
|
53041-0
|
DNA
region
of
interest
panel
-
Blood
or
Tissue
by
Molecular
genetics
method
|
|
53042-8
|
DNA
marker
assessed
panel
-
Blood
or
Tissue
by
Molecular
genetics
method
|
|
53043-6
|
DNA
marker
analysis
test
coverage
panel
-
Blood
or
Tissue
by
Molecular
genetics
method
|
|
53044-4
|
DNA
marker
identified
panel
-
Blood
or
Tissue
by
Molecular
genetics
method
|
|
53261-4
|
Amino
acid
newborn
screen
panel
|
|
53262-2
|
Carnitine
newborn
screen
panel
|
|
53263-0
|
Urinalysis
yeast
variants
panel
-
Urine
by
Computer
assisted
method
|
|
53264-8
|
Urinalysis
yeast
variants
panel
[#/volume]
-
Urine
by
Computer
assisted
method
|
|
53267-1
|
Urinalysis
yeast
variants
panel
[#/area]
-
Urine
by
Computer
assisted
method
|
|
53270-5
|
Urinalysis
type
of
non-squamous
epithelial
cells
panel
-
Urine
by
Computer
assisted
method
|
|
53273-9
|
Urinalysis
type
of
non-squamous
epithelial
cells
panel
[#/volume]
-
Urine
by
Computer
assisted
method
|
|
53276-2
|
Urinalysis
type
of
non-squamous
epithelial
cells
panel
[#/area]
-
Urine
by
Computer
assisted
method
|
|
53277-0
|
Urinalysis
type
of
cast
panel
-
Urine
by
Computer
assisted
method
|
|
53281-2
|
Urinalysis
type
of
cast
panel
[#/volume]
-
Urine
by
Computer
assisted
method
|
|
53293-7
|
Urinalysis
microscopic
panel
[#/area]
-
Urine
sediment
by
Automated
count
|
|
53295-2
|
Urinalysis
type
of
crystal
panel
[#/volume]
-
Urine
by
Computer
assisted
method
|
|
53305-9
|
Urinalysis
type
of
crystal
panel
[#/area]
-
Urine
by
Computer
assisted
method
|
|
53325-7
|
Urinalysis
type
of
crystal
panel
-
Urine
by
Computer
assisted
method
|
|
53330-7
|
Urinalysis
type
of
cast
panel
[#/area]
-
Urine
by
Computer
assisted
method
|
|
53333-1
|
Urinalysis
other
formed
elements
panel
-
Urine
by
Computer
assisted
method
|
|
53351-3
|
Urinalysis
other
formed
elements
panel
[#/volume]
-
Urine
by
Computer
assisted
method
|
|
53575-7
|
VAP
cholesterol
panel
-
Serum
or
Plasma
|
|
53598-9
|
Irritable
bowel
disease
prognostic
panel
-
Serum
or
Plasma
by
Immunoassay
|
|
53703-5
|
Mycobacterium
bovis
tuberculin
stimulated
gamma
interferon
panel
-
Blood
|
|
53705-0
|
Myasthenia
gravis
evaluation
pediatric
panel
-
Serum
|
|
53706-8
|
Myasthenia
grav
eval
adult
rflx
panel
-
Serum
|
|
53745-6
|
Benzodiazepines
panel
-
Urine
|
|
53746-4
|
Barbiturates
panel
-
Urine
|
|
53747-2
|
Cocaine
panel
-
Urine
|
|
53759-7
|
Natural
killer
cell
panel
-
Blood
by
Flow
cytometry
(FC)
|
|
53764-7
|
Prostate
specific
Ag
panel
-
Serum
or
Plasma
|
|
53766-2
|
Estrogen
fraction
panel
-
Serum
or
Plasma
|
|
53775-3
|
Hepatitis
A
virus
Ab
panel
-
Serum
|
|
53780-3
|
Chromium
panel
-
Urine
|
|
53781-1
|
Acetaminophen
and
Propoxyphene
panel
[Mass/volume]
-
Urine
|
|
53783-7
|
HTT
gene
mutation
panel
-
Blood
or
Tissue
by
Molecular
genetics
method
|
|
53800-9
|
Platelets
panel
-
Blood
by
Automated
count
|
|
53803-3
|
Transferrin.carbohydrate
deficient
panel
-
Serum
or
Plasma
|
|
53804-1
|
Arbovirus
IgG
panel
-
Serum
by
Immunofluorescence
|
|
53932-0
|
Streptococcus
pneumoniae
14a
and
Corynebacterium
diphtheriae
toxin
and
Clostridium
tetani
toxin
Ab.IgG
panel
-
Serum
|
|
54075-7
|
Endocrine
newborn
screening
panel
(SI
units)
|
|
54076-5
|
Endocrine
newborn
screening
panel
|
|
54077-3
|
Thyroid
newborn
screening
panel
(SI
units)
|
|
54078-1
|
Cystic
fibrosis
newborn
screening
panel
|
|
54079-9
|
Galactosemia
newborn
screening
panel
|
|
54080-7
|
Galactosemia
newborn
screening
panel
(SI
units)
|
|
54081-5
|
Hemoglobinopathies
newborn
screening
panel
|
|
54082-3
|
Infectious
diseases
newborn
screening
panel
|
|
54089-8
|
Newborn
screening
panel
American
Health
Information
Community
(AHIC)
|
|
54090-6
|
Thyroid
newborn
screening
panel
|
|
54097-1
|
Organophosphonate
nerve
agent
metabolite
panel
[Mass/volume]
-
Urine
|
|
54111-0
|
Newborn
hearing
screening
panel
|
|
54145-8
|
Bacterial
vaginosis
and
vaginitis
DNA
panel
-
Vaginal
fluid
by
Probe
and
signal
amplification
method
|
|
54225-8
|
Immune
response
panel
-
Unspecified
specimen
by
Flow
cytometry
(FC)
|
|
54226-6
|
Lymphoma
panel
-
Unspecified
specimen
by
Flow
cytometry
(FC)
|
|
54227-4
|
Lymphoma
-
acute
screen
panel
-
Unspecified
specimen
by
Flow
cytometry
(FC)
|
|
54228-2
|
Lymphoma
-
CLL
screen
panel
-
Unspecified
specimen
by
Flow
cytometry
(FC)
|
|
54229-0
|
Lymphoma
-
T-cell
screen
panel
-
Unspecified
specimen
by
Flow
cytometry
(FC)
|
|
54230-8
|
Cell
count
and
Diff
panel
with
Gluc
and
Prot
-
Cerebral
spinal
fluid
|
|
54231-6
|
Semen
analysis
fertility
panel
|
|
54232-4
|
Metabolic
panel.large
animal
-
Serum
or
Plasma
|
|
54233-2
|
Metabolic
panel.small
animal
-
Serum
or
Plasma
|
|
54234-0
|
Cell
count
and
Diff
panel
with
Gluc
and
Prot
-
Body
fluid
|
|
54235-7
|
Cortisol
challenge
panel
-
Saliva
(oral
fluid)
|
|
54246-4
|
Protein
and
Glucose
panel
[Mass/volume]
-
Body
fluid
|
|
54450-2
|
CYP2C9
and
VKORC1
panel
-
Blood
or
Tissue
by
Molecular
genetics
method
|
|
54932-9
|
Centers
for
Environmental
Health
abrine
and
ricinine
panel
[Mass/volume]
-
Urine
|
|
55101-0
|
Respiratory
virus
panel
-
Unspecified
specimen
by
Organism
specific
culture
|
|
55116-8
|
Centers
for
Environmental
Health
volatile
organic
compounds
panel
[Mass/volume]
-
Serum
or
Plasma
|
|
55117-6
|
Centers
for
Environmental
Health
trace
metals
screen
panel
[Mass/volume]
-
Urine
|
|
55118-4
|
Centers
for
Environmental
Health
trace
metals
panel
[Mass/volume]
-
Urine
|
|
55119-2
|
Centers
for
Environmental
Health
nitrogen
mustard
metabolite
panel
[Mass/volume]
-
Urine
|
|
55120-0
|
Centers
for
Environmental
Health
metabolic
toxin
panel
[Mass/volume]
-
Urine
|
|
55121-8
|
Multiple
sclerosis
panel
-
Serum
and
CSF
|
|
55150-7
|
Anaplasma
phagocytophilum
IgG
and
IgM
panel
-
Serum
Qualitative
|
|
55151-5
|
Aldosterone
and
Renin
panel
-
Plasma
|
|
55152-3
|
Amiodarone
and
Desethylamiodarone
panel
[Mass/volume]
-
Serum
or
Plasma
|
|
55153-1
|
Biotinidase
panel
-
Serum
or
Plasma
|
|
55155-6
|
Flunitrazepam
and
7-Aminoflunitrazepam
panel
[Mass/volume]
-
Urine
|
|
55157-2
|
Risperidone
and
9-Hydroxyrisperidone
panel
-
Serum
or
Plasma
|
|
55160-6
|
Adenovirus
IgG
and
IgM
panel
-
Serum
|
|
55161-4
|
Bordetella
pertussis
IgA
and
IgG
panel
-
Serum
by
Immunoassay
|
|
55162-2
|
HTLV
1+2
Ab
panel
-
Serum
Qualitative
|
|
55163-0
|
Streptococcus
pyogenes
enzyme
Ab
panel
-
Serum
Qualitative
|
|
55164-8
|
Paroxysmal
nocturnal
panel
-
Blood
|
|
55207-5
|
Genetic
analysis
discrete
result
panel
-
Blood
or
Tissue
by
Molecular
genetics
method
|
|
55208-3
|
DNA
analysis
discrete
sequence
variation
panel
-
Blood
or
Tissue
by
Molecular
genetics
method
|
|
55231-5
|
Electrolytes
panel
-
Blood
|
|
55232-3
|
Genetic
analysis
summary
panel
-
Blood
or
Tissue
by
Molecular
genetics
method
|
|
55233-1
|
Genetic
analysis
master
panel
-
Blood
or
Tissue
by
Molecular
genetics
method
|
|
55234-9
|
Alpha
thalassemia
gene
deletion
panel
[Presence]
-
Blood
by
Molecular
genetics
method
|
|
55235-6
|
Abnormal
hemoglobin
gene
panel
-
Blood
by
Molecular
genetics
method
|
|
55255-4
|
Pyridinoline
panel
-
Urine
|
|
55295-0
|
Protein
electrophoresis
and
Immunoglobulins
panel
-
Serum
|
|
55394-1
|
Protein
and
Glucose
panel
-
Cerebral
spinal
fluid
|
|
55395-8
|
Phospholipid
IgA
and
IgG
and
IgM
panel
-
Serum
|
|
55396-6
|
Beta
2
glycoprotein
1
IgA
and
IgG
panel
-
Serum
|
|
55397-4
|
Short
myasthenia
gravis
panel
-
Serum
|
|
55398-2
|
Short
Fibrin
D-dimer
FEU
and
DDU
panel
-
Platelet
poor
plasma
|
|
55399-0
|
Diabetes
tracking
panel
|
|
55401-4
|
Warfarin
tracking
panel
-
Platelet
poor
plasma
|
|
55402-2
|
West
Nile
virus
IgG
and
IgM
panel
-
Serum
|
|
55403-0
|
Asthma
tracking
panel
|
|
55405-5
|
Heart
failure
tracking
panel
|
|
55409-7
|
Exercise
tracking
panel
|
|
55413-9
|
Pedometer
tracking
panel
|
|
55415-4
|
Oxygen
therapy
tracking
panel
|
|
55417-0
|
Short
blood
pressure
panel
|
|
55418-8
|
Weight
and
Height
tracking
panel
|
|
55419-6
|
Home
drug
screening
panel
-
Urine
|
|
55427-9
|
Seizure
disorder
tracking
panel
|
|
55429-5
|
Short
blood
count
panel
-
Blood
|
|
55441-0
|
Antithrombin
Ag
in
Platelet
poor
plasma
|
|
55442-8
|
Antithrombin
in
Platelet
poor
plasma
|
|
55443-6
|
Cardiolipin
Ab
in
Serum
|
|
55444-4
|
Cardiolipin
IgA
Ab
in
Serum
|
|
55445-1
|
Cardiolipin
IgM
Ab
in
Serum
|
|
55446-9
|
Cardiolipin
IgG
Ab
in
Serum
|
|
55447-7
|
Coagulation
factor
VIII
Ag
in
Platelet
poor
plasma
|
|
55448-5
|
Complement
total
hemolytic
CH50
in
Serum
or
Plasma
|
|
55449-3
|
Fibrin
D-dimer
in
Platelet
poor
plasma
|
|
55450-1
|
Fibrin+Fibrinogen
fragments
in
Serum
|
|
55451-9
|
Fibrin+Fibrinogen
fragments
in
Platelet
poor
plasma
|
|
55452-7
|
Fibrinogen
in
Platelet
poor
plasma
|
|
55453-5
|
Haptoglobin
in
Serum
or
Plasma
|
|
55454-3
|
Hemoglobin
A1c
in
Blood
|
|
55455-0
|
Hemoglobin
F
in
Unspecified
specimen
|
|
55456-8
|
Hemoglobin
S
in
Blood
|
|
55457-6
|
Free
Hemoglobin
in
Plasma
|
|
55458-4
|
Interferon
alpha
in
Serum
or
Plasma
|
|
55459-2
|
Prekallikrein
(Fletcher
Factor)
in
Platelet
poor
plasma
|
|
55460-0
|
Protein
C
Ag
in
Platelet
poor
plasma
|
|
55461-8
|
Protein
C
in
Platelet
poor
plasma
|
|
55462-6
|
Thyrotropin
in
Serum
or
Plasma
|
|
55466-7
|
Influenza
virus
A
H1
2009
pandemic
RNA
panel
-
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
55728-0
|
Yersinia
sp
IgG
and
IgM
panel
-
Serum
|
|
55744-7
|
howRU
|
|
56146-4
|
Fungal
Ab
panel
-
Serum
|
|
56148-0
|
Smith
extractable
nuclear
Ab
and
Ribonucleoprotein
extractable
nuclear
Ab
panel
-
Serum
|
|
56149-8
|
Beta
2
glycoprotein
and
Cardiolipin
Ab
and
Phosphatidylserine
panel
-
Serum
|
|
56152-2
|
Beta
2
glycoprotein
1
Ab
IgA
and
IgG
and
IgM
panel
-
Serum
|
|
56156-3
|
Candida
albicans
IgA
and
IgG
and
IgM
Ab
panel
-
Serum
|
|
57019-2
|
Urinalysis
dipstick
W
Reflex
Culture
panel
-
Urine
|
|
57020-0
|
Urinalysis
dipstick
W
Reflex
Microscopic
panel
-
Urine
|
|
57021-8
|
CBC
W
Auto
Differential
panel
-
Blood
|
|
57022-6
|
CBC
W
Reflex
Manual
Differential
panel
-
Blood
|
|
57023-4
|
Auto
Differential
panel
-
Blood
|
|
57031-7
|
Herpesviruses
6
DNA
panel
-
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
57084-6
|
Fatty
acid
oxidation
newborn
screen
panel
|
|
57085-3
|
Organic
acid
newborn
screen
panel
|
|
57086-1
|
Congenital
adrenal
hyperplasia
newborn
screening
panel
|
|
57087-9
|
Biotinidase
newborn
screening
panel
|
|
57128-1
|
Newborn
Screening
Report
summary
panel
|
|
57698-3
|
Lipid
panel
with
direct
LDL
-
Serum
or
Plasma
|
|
57717-1
|
Newborn
screen
card
data
panel
|
|
57765-0
|
Disaccharidases
panel
-
Small
intestine
Tissue
|
|
57767-6
|
Trimipramine
and
Nortrimipramine
panel
-
Serum
or
Plasma
|
|
57770-0
|
Toxoplasma
gondii
IgG
and
IgM
panel
-
Serum
|
|
57772-6
|
Metanephrine.free
and
Normetanephrine.free
panel
[Moles/volume]
-
Serum
or
Plasma
|
|
57774-2
|
Colorado
tick
fever
virus
IgG
and
IgM
panel
[Titer]
-
Serum
|
|
57775-9
|
Valproate.free
and
Valproate
panel
-
Serum
or
Plasma
|
|
57776-7
|
Gliadin
peptide
IgA
and
IgG
panel
-
Serum
|
|
57777-5
|
Myeloperoxidase
Ab
and
Proteinase
3
panel
-
Serum
|
|
57778-3
|
Immunoglobulin
light
chains.free
panel
-
Serum
|
|
57780-9
|
Thyroglobulin
and
Thyrogobulin
Ab
panel
-
Serum
or
Plasma
|
|
57782-5
|
CBC
with
Ordered
Manual
Differential
panel
-
Blood
|
|
57794-0
|
Newborn
screening
test
results
panel
-
Dried
blood
spot
|
|
57795-7
|
Fecal
hydrolysis
panel
-
Stool
|
|
57803-9
|
Occult
blood
panel
-
Stool
by
Immunologic
method
|
|
58077-9
|
Urinalysis
complete
W
Reflex
Culture
panel
-
Urine
|
|
58091-0
|
Glucose-6-Phosphate
dehydrogenase
newborn
screen
panel
|
|
58092-8
|
Acylcarnitine
newborn
screen
panel
|
|
58406-0
|
Platelet
morphology
panel
-
Blood
|
|
58407-8
|
Leukocyte
morphology
panel
-
Blood
|
|
58408-6
|
Erythrocyte
morphology
panel
-
Blood
|
|
58410-2
|
Complete
blood
count
(hemogram)
panel
-
Blood
by
Automated
count
|
|
58431-8
|
Microalbumin
panel
-
24
hour
Urine
|
|
58446-6
|
Creatinine
24H
renal
clearance
adjusted
for
body
surface
area
panel
|
|
58447-4
|
Microalbumin/Creatinine
panel
in
24H
Urine
|
|
58713-9
|
Streptococcal
DNAse
B
and
ASO
antibodies
panel
-
Serum
|
|
58715-4
|
Adulterants
panel
-
Urine
|
|
58716-2
|
Testosterone.bioavailable
and
total
panel
-
Serum
or
Plasma
|
|
58732-9
|
Porphyrin
fractions
panel
-
Serum
or
Plasma
|
|
58733-7
|
Mycoplasma
pneumoniae
IgG
and
IgM
panel
-
Serum
|
|
58735-2
|
Alpha-1-Fetoprotein
panel
-
Amniotic
fluid
|
|
58736-0
|
Manganese
panel
-
Urine
|
|
58953-1
|
Meperidine
and
Normeperidine
panel
-
Urine
|
|
59049-7
|
Coccidioides
sp
IgG
and
IgM
panel
-
Unspecified
specimen
|
|
59059-6
|
Inflammatory
bowel
disease
Ab
7
panel
-
Serum
|
|
59062-0
|
Lipoprofile
panel
-
Serum
or
Plasma
|
|
59063-8
|
Lymphocyte
proliferation
panel
-
Blood
|
|
59257-6
|
Cell
count
and
Differential
panel
-
Pericardial
fluid
|
|
59852-4
|
North
American
Association
of
Central
Cancer
Registries,
Inc
(NAACCR,
Inc)
version
12
panel
|
|
60342-3
|
Borrelia
burgdorferi
IgG
panel
-
Serum
by
Immunoblot
(IB)
|
|
60343-1
|
Borrelia
burgdorferi
IgM
panel
-
Serum
by
Immunoblot
(IB)
|
|
60566-7
|
Respiratory
virus
DNA
and
RNA
12
panel
-
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
60587-3
|
Cell
count
and
Differential
panel
-
Peritoneal
dialysis
fluid
|
|
62300-9
|
Lysosomal
storage
disorders
newborn
screening
panel
|
|
62304-1
|
Fabry
disease
newborn
screening
panel
|
|
62307-4
|
Krabbe
disease
newborn
screening
panel
|
|
62311-6
|
Gaucher
disease
newborn
screening
panel
|
|
62315-7
|
Niemann
Pick
disease
A/B
newborn
screening
panel
|
|
62333-0
|
Severe
combined
immunodeficiency
(SCID)
newborn
screening
panel
|
|
62341-3
|
Borrelia
burgdorferi
IgG+IgM
with
reflex
to
immune
blot
panel
-
Serum
|
|
62426-2
|
Bordetella
sp
DNA
panel
-
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
63414-7
|
Pompe
disease
newborn
screening
panel
|
|
63430-3
|
Human
coronavirus
RNA
panel
-
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
63486-5
|
Nut
allergen
panel
-
Serum
|
|
64017-7
|
Chlamydia
trachomatis
and
Neisseria
gonorrhoeae
rRNA
panel
-
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
64116-7
|
Hemoglobin
observations
newborn
screening
panel
|
|
64418-7
|
KIR
genotyping
panel
-
Blood
or
Tissue
|
|
64433-6
|
Fragile
X
protein
(FMRP)
panel
-
Blood
|
|
65632-2
|
Clozapine
and
Norclozapine
panel
-
Serum
or
Plasma
|
|
65634-8
|
Creatinine
24
hour
urine
panel
-
24
hour
Urine
|
|
65750-2
|
Drugs
of
abuse
5
panel
-
Urine
by
Screen
method
|
|
65758-5
|
CD4
T-cell
absolute
panel
-
Blood
|
|
65759-3
|
T-cell
subsets
CD4
and
CD8
panel
-
Blood
|
|
65833-6
|
Address
Facility
|
|
67767-4
|
HEDIS
2012
panel
|
|
67790-6
|
Thromboelastography
panel
-
Blood
|
|
67795-5
|
Vital
signs,
weight,
height,
head
circumference
and
oximetry
panel
HITSP
|
|
67822-7
|
Fentanyl
and
Norfentanyl
panel
-
Urine
|
|
67866-4
|
Babesia
identification
panel
-
Unspecified
specimen
|
|
68314-4
|
Meperidine
and
Normeperidine
panel
-
Serum
or
Plasma
|
|
68315-1
|
Transcortin
and
Cortisol.free
panel
-
Serum
or
Plasma
|
|
68317-7
|
Metanephrine,
Normetanephrine
and
Creatinine
panel
-
Urine
|
|
68318-5
|
Hypoglycemics
panel
-
Serum
or
Plasma
|
|
68320-1
|
Polio
virus
Ab
panel
[Titer]
-
Serum
|
|
68501-6
|
Serotonin
release.heparin.unfractionated
and
low
molecular
weight
panel
-
Serum
|
|
68982-8
|
PFGE
panel
-
Isolate
|
|
68991-9
|
Epidemiologically
important
information
for
public
health
reporting
panel
|
|
68992-7
|
Specimen-related
information
panel
|
|
69008-1
|
Cocaine
panel
-
Meconium
by
Confirmatory
method
|
|
69018-0
|
Lymphocyte
proliferation
mitogen
panel
-
Blood
by
Flow
cytometry
(FC)
|
|
69021-4
|
Amphetamines
panel
-
Meconium
by
Confirmatory
method
|
|
69026-3
|
Opiates
panel
-
Meconium
by
Confirmatory
method
|
|
69034-7
|
Eastern
equine
encephalitis
virus
IgG
and
IgM
panel
-
Serum
by
Immunofluorescence
|
|
69035-4
|
Eastern
equine
encephalitis
virus
IgG
and
IgM
panel
-
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
69036-2
|
Western
equine
encephalitis
virus
IgG
and
IgM
panel
-
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
69039-6
|
Enterocyte
Ab
panel
-
Serum
|
|
69040-4
|
Chronic
urticaria
index
panel
-
Serum
or
Plasma
|
|
69041-2
|
Western
equine
encephalitis
virus
IgG
and
IgM
panel
-
Serum
by
Immunofluorescence
|
|
69042-0
|
Lymphocyte
proliferation
antigen
panel
-
Blood
by
Flow
cytometry
(FC)
|
|
69459-6
|
Care
record
summary
panel
|
|
69552-8
|
Thromboelastography
after
addtion
of
heparinase
panel
-
Blood
|
|
69554-4
|
Lactose
tolerance
panel
[Moles/volume]
in
Serum
or
Plasma
|
|
69555-1
|
Lactose
tolerance
panel
[Mass/volume]
in
Serum
or
Plasma
|
|
69571-8
|
Bacterial
vaginosis
DNA
and
score
panel
-
Vaginal
fluid
by
Probe
and
target
amplification
method
|
|
69581-7
|
National
(USA)
PFGE
cluster
code
or
CDC
cluster
[Identifier]
in
Isolate
|
|
69726-8
|
Tissue
transglutaminase
IgA
+
Gliadin
peptides
Ab.IgA
and
IgG
panel
-
Serum
|
|
69738-3
|
Differential
panel,
method
unspecified
-
Blood
|
|
69739-1
|
Drugs
of
abuse
panel
-
Urine
|
|
69740-9
|
Cell
count
panel
-
Pericardial
fluid
|
|
69741-7
|
Differential
panel
-
Pericardial
fluid
|
|
69742-5
|
CBC
W
Differential
panel,
method
unspecified
-
Blood
|
|
69999-1
|
Positive
airway
pressure
panel
|
|
70130-0
|
Rickettsia
typhus
group
and
Rickettsia
spotted
fever
group
acute
and
convalescent
IgG
and
IgM
panel
-
Serum
by
Immunofluorescence
|
|
70161-5
|
Chlamydia
trachomatis
and
Neisseria
gonorrhoeae
rRNA
panel
-
Urine
by
Probe
and
target
amplification
method
|
|
70162-3
|
Chlamydia
trachomatis
and
Neisseria
gonorrhoeae
rRNA
panel
-
Urethra
by
Probe
and
target
amplification
method
|
|
70163-1
|
Chlamydia
trachomatis
and
Neisseria
gonorrhoeae
rRNA
panel
-
Cervix
by
Probe
and
target
amplification
method
|
|
70164-9
|
Chlamydia
trachomatis
and
Neisseria
gonorrhoeae
rRNA
panel
-
Vaginal
fluid
by
Probe
and
target
amplification
method
|
|
70219-1
|
Basic
metabolic
2008
panel
with
ionized
calcium
-
Serum
or
Plasma
|
|
71432-9
|
Human
papilloma
virus
16
and
18
and
31+33+35+39+45+51+52+56+58+59+66+68
DNA
-
Cervix
|
|
71775-1
|
Mycobacterium
tuberculosis
stimulated
gamma
interferon
panel
-
Blood
|
|
72103-5
|
Acute
and
chronic
leukemia
fusion
transcript
panel
-
Blood
or
Tissue
by
Molecular
genetics
method
|
|
72104-3
|
Acute
and
chronic
leukemia
fusion
transcript
per
control
transcript
panel
-
Blood
or
Tissue
by
Molecular
genetics
method
|
|
72105-0
|
Vital
signs
and
oximetry
-
admission,
home
health,
interim,
discharge
[CARE]
|
|
72171-2
|
Glucose
tolerance
2
hours
panel
-
Serum
or
Plasma
|
|
72199-3
|
HEDIS
2013
panel
|
|
72203-3
|
Parathyrin.intact
intraoperative
panel
-
Serum
or
Plasma
|
|
72257-9
|
Platelet
function.collagen
+
Adenosine
diphosphate
induced
and
Epinephrine
induced
panel
-
Blood
|
|
72264-5
|
Bilirubin
excess
and
oxyhemoglobin
and
methemoglobin
and
xanthochromia
and
albumin
quotient
panel
-
Serum
and
CSF
|
|
72272-8
|
Amylase
and
triacylglycerol
lipase
panel
-
Serum
or
Plasma
|
|
72283-5
|
Nail
assessment
panel
|
|
72284-3
|
Skin
assessment
panel
|
|
72286-8
|
Wound
dressing
panel
|
|
72287-6
|
Wound
size
panel
|
|
72292-6
|
Wound
exudate
panel
|
|
72299-1
|
Wound
tunneling
and
undermining
panel
|
|
72369-2
|
Body
site
identification
panel
|
|
72372-6
|
Wound
bed
and
edge
panel
|
|
72393-2
|
Cell
count
and
Differential
panel
-
Vitreous
fluid
by
Manual
count
|
|
72394-0
|
Cell
count
panel
-
Vitreous
fluid
by
Manual
count
|
|
72395-7
|
Differential
panel
-
Vitreous
fluid
|
|
72476-5
|
Methadone
panel
-
Saliva
(oral
fluid)
by
Confirmatory
method
|
|
72478-1
|
Synthetic
cannabinoids
panel
-
Urine
by
Confirmatory
method
|
|
72479-9
|
Drugs
of
abuse
panel
-
Blood
by
Screen
method
|
|
72480-7
|
Barbiturates
panel
-
Blood
by
Confirmatory
method
|
|
72481-5
|
Candida
sp
6
panel
-
Vaginal
fluid
by
Probe
and
target
amplification
method
|
|
72488-0
|
Beta
2
glycoprotein
1
IgG
and
IgM
panel
-
Serum
|
|
72661-2
|
Intrinsic
coagulation
factor
activity
4
panel
-
Platelet
poor
plasma
by
Coagulation
assay
|
|
72662-0
|
Extrinsic
coagulation
factor
activity
4
panel
-
Platelet
poor
plasma
|
|
72670-3
|
Metanephrine,
Normetanephrine,
3-Methoxytyramine
and
Creatinine
panel
-
Urine
|
|
72694-3
|
Cholinesterase
activity
panel
-
Serum
or
Plasma
|
|
72695-0
|
Erythrocyte
enzyme
panel
-
Red
Blood
Cells
|
|
72718-0
|
Borderline
symptom
list
-
behavior
supplement
|
|
72719-8
|
Borderline
symptom
list
-
23
item
[BSL-23]
|
|
72727-1
|
Del(13)(q14)
and
del(17)(p13)
in
Blood
or
Tissue
|
|
72828-7
|
Chlamydia
trachomatis
and
Neisseria
gonorrhoeae
DNA
panel
-
Unspecified
specimen
|
|
72852-7
|
Cytomegalovirus
resistance
panel
by
Genotype
method
|
|
72862-6
|
Hepatitis
C
virus
resistance
panel
by
Genotype
method
|
|
72886-5
|
CYP2D6
gene
and
CYP2C19
gene
mutation
analysis
panel
-
Blood,
Tissue
or
Saliva
|
|
72892-3
|
Staphylococcus
aureus
and
Methicillin
(mecA)
genes
panel
by
Probe
and
target
amplification
method
|
|
72905-3
|
Neutrophil
Ab
and
HLA
Ab
screen
panel
-
Serum
or
Plasma
|
|
72906-1
|
HNA
Ab
panel
-
Serum
or
Plasma
|
|
72907-9
|
HNA
genotype
panel
-
Serum
or
Plasma
|
|
72908-7
|
Drug
induced
platelet
Ab
panel
-
Serum
or
Plasma
|
|
72909-5
|
Drug
induced
neutrophil
Ab
panel
-
Serum
or
Plasma
|
|
73660-3
|
Propoxyphene
panel
-
Saliva
(oral
fluid)
|
|
73661-1
|
Methadone
panel
-
Saliva
(oral
fluid)
by
Screen
method
|
|
73662-9
|
Benzodiazepines
panel
-
Saliva
(oral
fluid)
by
Screen
method
|
|
73663-7
|
Barbiturates
panel
-
Saliva
(oral
fluid)
by
Confirmatory
method
|
|
73724-7
|
Bile
acid
dihydroxy
and
trihydroxy
panel
-
Serum
or
Plasma
|
|
73725-4
|
Bile
acid
panel
-
24
hour
Stool
|
|
73738-7
|
Newborn
screening
test
results
panel
-
Point
of
Care
|
|
73741-1
|
Newborn
hearing
screen
panel
of
Ear
-
left
|
|
73744-5
|
Newborn
hearing
screen
panel
of
Ear
-
right
|
|
73790-8
|
Neonatal
skin
risk
assessment
scale
panel
[NSRAS]
|
|
73805-4
|
CCHD
newborn
screening
panel
|
|
73852-6
|
7-Dehydrocholesterol
and
8-Dehydrocholesterol
panel
-
Serum
or
Plasma
|
|
73865-8
|
Catecholamines
3
panel
[Moles/volume]
-
Plasma
|
|
73866-6
|
Catecholamines
3
and
creatinine
panel
[Molar
ratio]
-
Urine
|
|
73879-9
|
Catecholamine
metabolites
and
creatinine
panel
-
Urine
|
|
73885-6
|
Steroid
fractions
panel
-
24
hour
Urine
|
|
73886-4
|
Steroid
fractions
panel
-
Urine
|
|
73897-1
|
Chronic
lyme
disease
panel
-
Blood
by
Flow
cytometry
(FC)
|
|
73967-2
|
Noninvasive
prenatal
fetal
aneuploidy
test
panel
-
Plasma
cell-free
DNA
|
|
73979-7
|
Keyhole
limpet
hemocyanin
Ab
panel
-
Serum
or
Plasma
|
|
74028-2
|
Virtual
Medical
Record
for
Clinical
Decision
Support
panel
HL7.VMR-CDS
|
|
74029-0
|
Periodontal
attachment
-
recommended
CDA
set
|
|
74032-4
|
Arbovirus
IgM
panel
-
Serum
|
|
74080-3
|
Patient
safety
event
report
-
hospital:
medication
or
other
substance
-
version
1.2
[AHRQ]
|
|
74182-7
|
NMMDS
job
satisfaction
panel
|
|
74219-7
|
Weight
difference
pre
dialysis
and
post
dialysis
panel
|
|
74281-7
|
Mycobacterium
tuberculosis
stimulated
gamma
interferon
and
spot
count
panel
-
Blood
|
|
74352-6
|
Cryoglobulin
and
cryofibrinogen
panel
-
Serum
and
Plasma
|
|
74353-4
|
Sodium
and
Potassium
panel
[Moles/volume]
-
Blood
|
|
74408-6
|
Middle
east
respiratory
syndrome
coronavirus
(MERS-CoV)
RNA
panel
-
Unspecified
specimen
|
|
74409-4
|
MICA
IgG
panel
-
Serum
|
|
74410-2
|
Polychlorinated
biphenyl
(PCB)
panel
-
Serum
or
Plasma
by
Confirmatory
method
|
|
74412-8
|
CBC
W
Differential
panel
-
Cord
blood
|
|
74413-6
|
Differential
panel
-
Cord
blood
|
|
74439-1
|
Gamma
aminobutyrate
free
and
total
panel
-
Cerebral
spinal
fluid
|
|
74445-8
|
Porphyrin
fractions
panel
[Moles/mass]
-
Stool
|
|
74446-6
|
Stone
analysis
panel
|
|
74447-4
|
Sugars
and
polyols
panel
[Molar
ratio]
-
Urine
|
|
74514-1
|
Amino
acids
panel
[Moles/volume]
-
Urine
|
|
74519-0
|
Complement
functional
activity
panel
-
Serum
|
|
74526-5
|
Delta
aminolevulinate,
porphobilinogen
and
creatinine
panel
-
24
hour
Urine
|
|
74527-3
|
Delta
aminolevulinate,
porphobilinogen
and
creatinine
panel
-
Urine
|
|
74545-5
|
Tryptophan-related
indole
profiling
panel
-
Platelet
rich
plasma
|
|
74633-9
|
Dimethylacetal
(DMA)
panel
-
Fibroblast
|
|
74634-7
|
Dimethylacetal
(DMA)
panel
-
Red
Blood
Cells
|
|
74635-4
|
Bacterial
vaginosis
DNA
panel
-
Vaginal
fluid
by
Probe
and
target
amplification
method
|
|
74728-7
|
Vital
signs,
weight,
height,
head
circumference,
oximetry,
BMI,
and
BSA
panel
-
HL7.CCDAr1.1
|
|
74749-3
|
Gram
positive
blood
culture
panel
by
Nucleic
acid
capture
and
probe
detection
on
Positive
blood
culture
|
|
74760-0
|
Hydrocodone
and
hydromorphone
panel
-
Urine
by
Confirmatory
method
|
|
74764-2
|
Soluble
fms-like
tyrosine
kinase-1
and
placental
growth
factor
panel
-
Serum
or
Plasma
|
|
74773-3
|
Immunoglobulin
light
chains
and
heavy
chains
panel
-
Serum
or
Plasma
|
|
74787-3
|
Influenza
virus
B
Victoria
and
Yamagata
lineage
RNA
panel
-
Unspecified
specimen
|
|
74788-1
|
Lactulose
challenge
(hydrogen
breath
test)
panel
-
Exhaled
gas
|
|
74789-9
|
Fructose
challenge
(hydrogen
breath
test)
panel
-
Exhaled
gas
|
|
74790-7
|
Glucose
challenge
(hydrogen
breath
test)
panel
-
Exhaled
gas
|
|
74831-9
|
Metanephrine
and
Normetanephrine
panel
[Moles/volume]
-
Urine
|
|
74835-0
|
Porphyrin
fractions
panel
-
Stool
|
|
74874-9
|
Metabolic
disorder
therapy
monitoring
panel
-
Dried
blood
spot
|
|
74885-5
|
HER2
panel
-
Tissue
by
Fluorescent
in
situ
hybridization
(FISH)
|
|
74888-9
|
Sterols
panel
[Moles/volume]
-
Serum
or
Plasma
|
|
74914-3
|
Acylglycines
panel
[Molar
ratio]
-
Urine
|
|
74978-8
|
Cerebroside
sulfatase
and
N-Acetylgalactosamine-4-Sulfatase
panel
[Enzymatic
activity/mass]
-
Leukocytes
|
|
74991-1
|
Amino
acids
panel
[Molar
ratio]
-
Urine
|
|
74993-7
|
Chloride
and
sodium
panel
[Moles/volume]
-
Sweat
|
|
75021-6
|
Olanzapine
panel
-
Serum
or
Plasma
|
|
75199-0
|
Congenital
syphilis
case
investigation
and
report
panel
[CDC.CS]
|
|
75243-6
|
Norton
scale
panel
|
|
75256-8
|
Disability
information
and
assistance
needed
panel
[HHS.ACA
Section
4302.ONC]
|
|
75258-4
|
PROMIS
short
form
-
sleep
disturbance
-
4a
-
version
1.0
|
|
75259-2
|
PROMIS
short
form
-
pain
intensity
-
3a
-
version
1.0
|
|
75282-4
|
Nutrition
assessment
panel
|
|
75283-2
|
Food
and
nutrition
history
panel
|
|
75284-0
|
Food
and
nutrient
intake
panel
|
|
75285-7
|
Comparative
nutrition
assessment
standards
panel
|
|
75286-5
|
Nutrition
related
anthropometric
measurements
panel
|
|
75287-3
|
Food
and
beverage
intake
panel
|
|
75304-6
|
Nutrition
status
observation
panel
|
|
75418-4
|
PCORI
patient-reported
outcomes
common
measures
-
core
and
recommended
[PROMIS]
|
|
75419-2
|
PCORI
patient-reported
outcomes
recommended
measures
[PROMIS]
|
|
75420-0
|
PCORI
patient-reported
outcomes
core
pediatric
measures
[PROMIS]
|
|
75421-8
|
PCORI
patient-reported
outcomes
core
adult
measures
[PROMIS]
|
|
75515-7
|
Lupus
anticoagulant
aPTT
and
dRVVT
screening
panel
W
Reflex
|
|
75533-0
|
NMMDS
accreditation,
certification,
and
licensure
panel
|
|
75547-0
|
Noninvasive
prenatal
fetal
aneuploidy
and
microdeletion
panel
based
terminology
systems).
on
Plasma
cell-free+WBC
DNA
by
Dosage
of
chromosome-specific
circulating
cell
free
(ccf)
DNA
|
|
75619-7
|
National
healthcare
survey
panel
[NAMCS]
|
|
75620-5
|
TNM
clinical
staging
before
treatment
panel
Cancer
|
|
75621-3
|
TNM
pathologic
staging
after
surgery
panel
Cancer
|
|
75622-1
|
HIV
1
and
2
tests
-
Meaningful
Use
Set
|
|
75635-3
|
Rheumatoid
arthritis
disease
activity
panel
-
Serum
or
Plasma
by
VectraDA
|
|
75641-1
|
Electrolytes
3
panel
-
Cerebral
spinal
fluid
|
|
75667-6
|
Electrolytes
3
panel
-
24
hour
Urine
|
|
75673-4
|
Gram
negative
blood
culture
panel
by
Nucleic
acid
capture
and
probe
detection
on
Positive
blood
culture
|
|
75689-0
|
Iron
panel
-
Serum
or
Plasma
|
|
75697-3
|
Bilirubin
fractions
panel
[Moles/volume]
-
Serum
or
Plasma
|
|
75742-7
|
Dartmouth
COOP
Functional
Assessment
Charts
-
2
weeks
|
|
75743-5
|
Dartmouth
COOP
Functional
Assessment
Charts
-
4
weeks
|
|
75772-4
|
Advance
directives
panel
[ADVault]
|
|
75814-4
|
Antihistamines
panel
-
Serum
or
Plasma
or
Urine
by
Screen
method
|
|
75815-1
|
Antipsychotics
drug
panel
-
Blood
or
Urine
by
Screen
method
|
|
75842-5
|
Clinical
disease
activity
index
[CDAI]
|
|
75843-3
|
Simplified
disease
activity
index
[SDAI]
|
|
75858-1
|
Sterols
panel
[Mass/volume]
-
Serum
or
Plasma
|
|
75860-7
|
Hepatitis
A
virus
RNA
and
Parvovirus
B19
DNA
panel
-
Plasma
from
donor
by
Probe
and
target
amplification
method
|
|
75881-3
|
Lupus
anticoagulant
aPTT,
dRVVT
and
PT
screening
panel
W
Reflex
|
|
76067-8
|
Abbreviated
Injury
Scale
panel
AAAM
|
|
1004-1
|
Direct
antiglobulin
test.complement
specific
reagent
[Presence]
on
Red
Blood
Cells
|
|
1007-4
|
Direct
antiglobulin
test.poly
specific
reagent
[Presence]
on
Red
Blood
Cells
|
|
1015-7
|
Ew
Ag
[Presence]
on
Red
Blood
Cells
|
|
1021-5
|
E
Ag
[Presence]
on
Red
Blood
Cells
|
|
10226-9
|
Oxygen
content
in
Intravascular
space
|
|
10244-2
|
Oxygen
content
in
Pulmonary
artery
-
left
|
|
10245-9
|
Oxygen
content
in
Main
pulmonary
artery
|
|
10246-7
|
Oxygen
content
in
Pulmonary
artery
-
right
|
|
10247-5
|
Oxygen
content
in
Pulmonary
wedge
|
|
1027-2
|
Fy
sup(a)
Ag
[Presence]
on
Red
Blood
Cells
|
|
1033-0
|
Fy
sup(b)
Ag
[Presence]
on
Red
Blood
Cells
|
|
10331-7
|
Rh
[Type]
in
Blood
|
|
10334-1
|
Cancer
Ag
125
[Units/volume]
in
Serum
or
Plasma
|
|
10336-6
|
Gonadotropin
peptide
[Mass/volume]
in
Urine
|
|
10337-4
|
Procollagen
peptide.type
1
[Mass/volume]
in
Serum
|